Josh Rosenholtz focuses his practice on commercial finance transactions with an emphasis on venture debt, fund finance and middle-market credit facilities. He represents banks, non-institutional lenders and companies.
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
October 13, 2021
Cooley advised Flexion Therapeutics, a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, on its agreement to sell to Pacira BioSciences. Lawyers Miguel Vega, Kevin Cooper, Sean Clayton and Matthew Silverman led the Cooley team advising Flexion.
Cooley advised Coupang, one of Asia’s largest ecommerce companies, on its $4.55 billion initial public offering of 130 million shares of Class A common stock, including 30 million shares sold by selling stockholders. In addition, Cooley advised Coupang on its $1 billion credit line by a syndicate of lenders. Lawyers Eric Jensen, Calise Cheng and Natalie Karam led the global Cooley team advising Coupang on its IPO, which is the biggest IPO in the US this year and one of the top 25 listings of all time based on deal size. Patrick Flanagan led the Cooley team advising on the credit line.
Cooley advised Rapid7 on its offering of $230 million aggregate principal amount of 2.25% Convertible Senior Notes due 2025 (the "Notes"), including an additional $30.0 million aggregate principal amount of Notes issued pursuant to the full exercise of the initial purchasers' option to purchase additional Notes, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Rapid7 is a leading cyber security solutions provider, on a mission to make successful security tools and practices accessible to all.